NEWS

Screen%20Shot%202021-02-23%20at%201.07_e

Orpha Labs AG Initiates Compassionate Use Program for ORL-101 in Leukocyte Adhesion Deficiency Type II (LAD-II)

First Patient to Receive ORL-101 in Israel This Week

Feb 08, 2021, 02:00 ET